Simplifying radiation planning for nasopharyngeal cancer
Part of Cancer clinical trials.
This study tests a simpler way to plan radiation for a type of throat cancer called nasopharyngeal carcinoma. It uses a standard method to outline the area needing treatment, which may make planning faster and more consistent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with nasopharyngeal cancer through a biopsy.
- Your cancer has not spread to other parts of the body (no distant metastases).
- You had an MRI of your nasopharynx and neck before starting treatment, and you completed your first course of treatment at the hospital running this study.
- You are in good overall health, with a performance status score of 0 or 1 (meaning you can carry out daily activities without help).
- You are willing to sign a consent form and come back for regular follow-up visits.
- You do not have any other active cancer or serious health issues like uncontrolled high blood pressure, heart disease, or an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining a special scope (NBI) with MRI scans can help doctors better target radiation therapy for a specific type of nose/throat cancer that affects only one side. It aims to make treatment more precise and reduce side effects.
This trial tests whether it is safe to skip radiation to part of the neck for people with nasopharyngeal carcinoma whose lymph nodes are only in a certain area. The goal is to reduce side effects while still controlling the cancer.
This trial tests whether intense radiation therapy (IMRT) alone is effective for people with stage IB nasopharyngeal carcinoma (a type of head and neck cancer) that has not spread to lower lymph nodes or formed large, matted nodes. If you qualify, you would receive targeted radiation without chemotherapy.
This trial compares two treatments for early-stage nasopharyngeal cancer that has returned after radiation: surgery versus intensity-modulated radiation therapy (IMRT). The goal is to see which approach is more effective at controlling the cancer while keeping side effects manageable.
This trial tests a new way to plan radiation treatment for nasopharyngeal cancer, where the target area is tailored to each patient's tumor spread. It aims to improve effectiveness while reducing side effects.
This trial studies whether lowering the radiation dose to a smaller area around the tumor is safe and effective for people with newly diagnosed nasopharyngeal cancer that has not spread. It may reduce side effects while still curing the cancer.
Hear when a new Nasopharyngeal Carcinoma by AJCC V8 Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.